Details for Patent: 7,838,499
✉ Email this page to a colleague
Which drugs does patent 7,838,499 protect, and when does it expire?
Patent 7,838,499 protects BRENZAVVY and is included in one NDA.
This patent has thirty-five patent family members in twenty-nine countries.
Drugs Protected by US Patent 7,838,499
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Theracosbio | BRENZAVVY | bexagliflozin | TABLET;ORAL | 214373-001 | Jan 20, 2023 | RX | Yes | Yes | 7,838,499 | ⤷ Subscribe | Y | Y | AN ADJUNCT TO DIET AND EXERCISE TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES | ⤷ Subscribe | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,838,499
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 068016 | ⤷ Subscribe | |||
| Argentina | 110796 | ⤷ Subscribe | |||
| Australia | 2008288770 | ⤷ Subscribe | |||
| Brazil | PI0815708 | ⤷ Subscribe | |||
| Canada | 2697349 | ⤷ Subscribe | |||
| China | 101790311 | ⤷ Subscribe | |||
| Cyprus | 1119810 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
